Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis.

[1]  J. Lordan,et al.  Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. , 2013, Respiratory medicine.

[2]  Kathryn J. Quigley,et al.  Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis , 2013, Clinical and experimental immunology.

[3]  Jeremy S. Brown,et al.  Research priorities in bronchiectasis , 2012, Thorax.

[4]  D. Altmann,et al.  Immune regulation in idiopathic bronchiectasis , 2012, Annals of the New York Academy of Sciences.

[5]  Paolo Vineis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Mutagenesis.

[6]  J. Ioannidis,et al.  STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement , 2011, European Journal of Epidemiology.

[7]  G. Westergren-Thorsson,et al.  Infection and remodelling: a 21st century model of bronchiectasis? , 2011, European Respiratory Journal.

[8]  S. Khakoo,et al.  KIR/HLA Interactions and Pathogen Immunity , 2011, Journal of biomedicine & biotechnology.

[9]  M. Carrington,et al.  HLA/KIR restraint of HIV: surviving the fittest. , 2011, Annual review of immunology.

[10]  S Tonks,et al.  Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA. , 2010, Tissue antigens.

[11]  Derek Middleton,et al.  The extensive polymorphism of KIR genes , 2010, Immunology.

[12]  M. Carrington,et al.  Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex , 2009, Human molecular genetics.

[13]  F. Culley Natural killer cells in infection and inflammation of the lung , 2009, Immunology.

[14]  P. Gourraud,et al.  Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. , 2009, Tissue antigens.

[15]  S. Khakoo,et al.  Natural killer cells: integrating diversity with function , 2009, Immunology.

[16]  Smita Kulkarni,et al.  The Yin and Yang of HLA and KIR in human disease. , 2008, Seminars in immunology.

[17]  D. Hassett,et al.  NKG2D Is Critical for NK Cell Activation in Host Defense against Pseudomonas aeruginosa Respiratory Infection1 , 2008, The Journal of Immunology.

[18]  D. Altmann,et al.  Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity , 2008, Clinical and experimental immunology.

[19]  D. Altmann,et al.  Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease , 2007, Clinical and experimental immunology.

[20]  D. Middleton,et al.  Study of KIR genes in tuberculosis patients. , 2006, Tissue antigens.

[21]  M. Carrington,et al.  The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. , 2006, Annual review of genomics and human genetics.

[22]  J. Trowsdale,et al.  HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. , 2006, American journal of respiratory and critical care medicine.

[23]  P. Parham,et al.  KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand1 , 2005, The Journal of Immunology.

[24]  B. Koeleman,et al.  KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. , 2003, Diabetes.

[25]  Michael J. Wilson,et al.  Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.

[26]  D. Middleton,et al.  Molecular diversity of the HLA-C gene identified in a caucasian population. , 2002, Human immunology.

[27]  D Middleton,et al.  Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. , 2000, Tissue antigens.

[28]  D Middleton,et al.  New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.

[29]  Derek Middleton,et al.  New allele frequency database: www.allelefrequencies.net , 2003 .